WHO ICTRP trial

The effect of lipoic acid supplementation on stroke patients

IRCT2016051811763N23 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT2016051811763N23
Public title The effect of lipoic acid supplementation on stroke patients
Scientific title The effect of alpha-lipoic acid supplementation on some cardiovascular indicators, inflammatory markers, and lipid profile in patients with stroke
Primary sponsor Vice President of Research, Isfahan University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 2-3
Countries Iran (Islamic Republic of)
Conditions strok. Stroke, not specified as haemorrhage or infarction;Stroke, not specified as haemorrhage or infarction
Interventions Intervention 1: lipoic acid 600 mg. Intervention 2: corn starch 600 mg.;Treatment - Drugs;Placebo;lipoic acid 600 mg;corn starch 600 mg
Registration date Jun 29, 2016
Target size 80
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations